2025-2026

◎2023年度はこちら
◎2024年度はこちら

1. Gonzalez G, Carr MJ, Byrne H, Colgan A, Hare D, Sawa H, De Gascun CF, Matthijnssens J, Yandle Z.
   “Complex evolutionary dynamics including reassortment drive genome diversity in human rotavirus species A circulating in Ireland.”
   Infect Genet Evol.,135,105848,  2025 Oct 29. (2025 Oct 29),
   DOI: 10.1016/j.meegid.2025.105848
2. “Spatial gene expression analysis reveals pathological niches in Japanese encephalitis virus neuroinvasion”
   Proc Natl Acad Sci U S A.,122(43),e2515006122, Epub 2025 Oct 23. (2025 Oct 23),
   DOI: 10.1073/pnas.2515006122
3. Shawa M, Chambaro H, Kamboyi HK, Sulwe C, Chizimu JY, Nasilele SJ, Ogata S, Samutela M, Zorigt T, Mudenda S, Simbotwe M, Nsofwa M, Chanda J, Chabala F, Nundwe M, Ndebe J, Sinjani M, Hayashida K, Nao N, Chilengi R, Sawa H, Suzuki Y, Hang’ombe B, Kajihara M, Higashi H.
   “In silico characterization of chromosomally integrated blaCTX-M genes among clinical Enterobacteriaceae in Africa: insights from whole-genome analysis”
   Front Microbiol.,16,1655907. (2025 Sep 12),
   DOI: 10.3389/fmicb.2025.1655907
4. Bunuma EK, Keyyu J, Maziku J, Bitanyi S, Fyumagwa R, Changula K, Mubemba B, Simulundu E, Chitanga S, Horton DL, Ekiri AB, Sawa H, Muleya W.
   “Rabies Surveillance in Mainland Tanzania: A Scoping Review of Animal Rabies Occurrences (1993-2023)”
   Pathogens,14(9),919. (2025 Sep 11),
   DOI: 10.3390/pathogens14090919
5. Konishi K, Taoda Y, Igarashi M, Shishido T, Yasuo K, Hall WW, Orba Y, Sawa H, Sasaki M, Sato A.
   “A cap-dependent endonuclease inhibitor acts as a potent antiviral agent against La Crosse virus infection”
   Antimicrob Agents Chemother.,69(9),e0018625. (2025 Sep 3),
   DOI: 10.1128/aac.00186-25
6. Suzuki T, Miyata Y, Haga S, Itoh Y, Tanaka T, Hishinuma T, Orba Y, Eshita Y, Sakai Y, Kurosu T, Tajima S, Lim CK, Saijo M, Yamanaka A, Phanitchat T, Morales Vargas RE, Okuzaki D, Sawa H, Satoh T, Akira S, Matsuura Y, Okamoto T.
   “Selective TLR ligand stimulation enhances in vivo mosquito-borne flavivirus pathogenicity”
   Cell Rep.,44(9),116210. Online ahead of print. (2025 Aug 29),
   DOI: 10.1016/j.celrep.2025.116210
7. Toba S, Uemura K, Sanaki T, Kusakabe S, Konishi K, Miki S, Maruyama Y, Iimuro A, Shishido T, Sasaki M, Orba Y, Hall WW, Sawa H, Sato A.
   “Synergistic antiviral activity of a cathepsin B/L inhibitor and a TMPRSS2 inhibitor against SARS-CoV-2 in vitro and in vivo”
   Virology.,612,110661. Epub 2025 Aug 21.. (2025 Aug 21),
   DOI: 10.1016/j.virol.2025.110661
8. Nakagawa Y, Kawaguchi Y, Hirose H, Hashiguchi T, Lee J, Hotta A, Kawamoto J, Sasaki M, Sawa H, Futaki S.
   “SARS-CoV-2 inhibition through mRNA delivery using engineered extracellular vesicles displaying the spike protein.”
   Biomaterials.,325,123594. Epub 2025 Aug 4. (2025 Aug 4),
   DOI: 10.1016/j.biomaterials.2025.123594
9. Sakurai Y, Fujioka Y, Maishi N, Takeda R, Ohba Y, Sasaki M, Teshirogi T, Ito W, Hida Y, Matsuda A, Kido K, Orba Y, Sa H, Hida K.
   “SARS-CoV-2 uptake and inflammatory response in senescent endothelial cells are regulated by the BSG/VEGFR2 pathway”
   Proc Natl Acad Sci U S A.,122(31),e2502724122. Epub 2025 Jul 28. (2025 Jul 28),
   DOI: 10.1073/pnas.2502724122
10. Nasilele SJ, Shawa M, Kamboyi HK, Phiri BSJ, Chambaro H, Lundu T, Nundwe M, Lungu A, Moonga L, Kajihara M, Sawa H, Suzuki Y, Higashi H, Siame A, Mudenda NB, Hang’ombe MB, Muzandu K.
    “Occurrence of cefotaxime-resistant and beta-lactamase-producing Enterobacteriales in poultry from small-scale farms in the Copperbelt province of Zambia.”
    JAC Antimicrob Resist.,7(4),dlaf125. eCollection 2025. (2025 Jul 22),
    DOI: 10.1093/jacamr/dlaf125
11. De’Sean Mears C, Tabata K, Ariizumi T, Hang’ombe BM, Qiu Y, Harima H, Kajihara M, Hall WW, Sasaki M, Sawa H, Orba Y.
    “Mosquito-borne alphaviruses in Zambia: Isolation and characterization of Eilat and Sindbis viruses.”
    Virus Res.,358,199604. Epub 2025 Jul 7. (2025 Jul 7),
    DOI: 10.1016/j.virusres.2025.199604
12. Unoh Y, Hirai K, Uehara S, Kawashima S, Nobori H, Sato J, Shibayama H, Hori A, Nakahara K, Kurahashi K, Takamatsu M, Yamamoto S, Zhang Q, Tanimura M, Dodo R, Maruyama Y, Sawa H, Watari R, Miyano T, Kato T, Sato T, Tachibana Y.
    “Discovery of the Clinical Candidate S-892216: A Second-Generation of SARS-CoV-2 3CL Protease Inhibitor for Treating COVID-19”
    J Med Chem.,68(20),21099-21119. Epub 2025 Jul 5. (2025 Jul 5),
    DOI: 10.1021/acs.jmedchem.5c00754
13. Ito W, Sakurai Y, Maishi N, Takeda R, Teshirogi T, Yu L, Hida Y, Sasaki M, Orba Y, Tsumita T, Watanabe H, Iimura T, Kubo T, Toba S, Sato A, Matsuda A, Kyuno D, Osanai M, Ohiro Y, Torigoe T, Sawa H, Hida K.
    “SARS-CoV-2 infection promotes lung thrombosis by inducing integrinβ3 expression in vascular endothelial cells”
    Sci Rep.,15(1),20447.  (2025 Jul 1),
    DOI: 10.1038/s41598-025-02784-4
14. Aklil Y, Takeuchi H, Gonzalez G, Inoue A, Maeda K, Kobayashi S, Itakura Y, Saito S, Sakuntabhai A, Sasaki M, Hall WW, Sawa H, Orba Y, Tabata K.
    “Development of a novel plate reader-based antibody-dependent enhancement (ADE) assay for orthoflavivirus infections”
    J Virol Methods.,338,115210. Epub 2025 Jun 24. (2025 Jun 24),
    DOI: 10.1016/j.jviromet.2025.115210
15. Ito J, Strange A, Liu W, Joas G, Lytras S; Genotype to Phenotype Japan (G2P-Japan) Consortium; Sato K.
    “A protein language model for exploring viral fitness landscapes”
    Nat Commun.,16(1),4236. (2025 May 13),
    DOI: 10.1016/j.meegid.2025.105848
16. Chambaro HM, Hayashida K, Moonga LC, Shawa M, Muleya W, Chizimu J, Squarre D, Sugi T, Yamagishi J, Ogata S, Kajihara M, Sawa H, Sanjoba C, Mwase ET, Chilengi R, Munsaka GH, Sarenje KL, Mulunda NR, Mutengo MM, Namangala B, Goto Y.
    “A high prevalence of dogs seropositive to Leishmania in Zambia”
    Parasitol Int.,108,103081. Online ahead of print. (2025 Apr 24),
    DOI: 10.1016/j.parint.2025.103081
17. Shawa M, Hayashida K, Nao N, Paudel A, Kamboyi H, Chambaro H, Mulavu M, Khumalo CS, Nundwe M, Zorigt T, Nakamura C, Qiu Y, Kawai N, Kasanga M, Chizimu J, Moonga L, Ndebe J, Simbotwe M, Ogata S, Samutela M, Nakajima C, Chilengi R, Mutengo M, Kajihara M, Sawa H, Hang’ombe B, Suzuki Y, Higashi H.
    “Development of a PCR-dipstick DNA chromatography-based tool for the detection of CTX-M- and TEM-producing Escherichia coli and Klebsiella pneumoniae isolated from patients in Kafue and Katete districts of Zambia”
    BMC Infect Dis.,25(1),541. (2025 Apr 16),
    DOI: 10.1186/s12879-025-10628-9
18. Kawakita T, Sekiya T, Kameda Y, Nomura N, Ohno M, Handabile C, Yamaya A, Fukuhara H, Anraku Y, Kita S, Toba S, Tsukamoto H, Sawa T, Oshiumi H, Itoh Y, Maenaka K, Sato A, Sawa H, Suzuki Y, Brown LE, Jackson DC, Kida H, Matsumoto M, Seya T, Shingai M.
    “ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4+ and CD8+ T-cell responses and neutralizing antibody induction”
    J Virol.,e0229024. Online ahead of print. (2025 Apr 15),
    DOI: 10.1128/jvi.02290-24
19. Singano N, Kainga H, Chatanga E, Nkhoma J, Njunga G, Chulu J, Tembo R, Sawa H, Muleya W.
    “One Health Lens on Rabies: Human-Bat Interactions and Genomic Insights of Rabies Virus in Rural Lilongwe, Malawi”
    Trop Med Infect Dis.,10(4),95. (2025 Apr 4),
    DOI: 10.3390/tropicalmed10040095